ICH guideline E17 on general principles for planning and design of multi-regional clinical trials -
With the increasing globalisation of drug development, it has become important that data from multi- regional clinical trials (MRCTs) can be accepted by regulatory authorities across regions and countries as the primary source of evidence to support marketing approval of drugs (medicinal products).
Click on this link for more information.
